Stockhead TV
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Imagion Biosystems.
RELATED STOCKHEAD STORIES
Health & Biotech
Bargain Barrel: Four ASX cancer-fighting stocks with market caps under $35 million
Health & Biotech
Imagion to start production of MagSense imaging agent for phase II breast cancer trial
Health & Biotech
The ASX biotechs aiming to catch cancer early
Health & Biotech
Imagion set to improve cancer detection through molecular MRI
News
ASX Small Caps Lunch Wrap: Sluggish day for the ASX as crude oil bleeds out 4.0pc
Health & Biotech
Health Check: Sleep-maker Resmed recovers from ‘nonsense’ sell-off spurred by rise of fat-busting drugs
Health & Biotech
Health Check: Thirsty Chimeric goes to the well for funding top-up
News
Closing Bell: Arcadium holders cash in, Oil rallies as Milton hits, and GYG keeps momentum going
Health & Biotech
Imagion raises $3m to advance MagSense cancer diagnosis platform
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: Imagion and Microba’s positive Phase 1 results; and LGP’s first mover advantage in France
Health & Biotech
ASX Health Stocks: Noxopharm jumps +50pc on mRNA vaccine results; Starpharma +25pc on Phase 2 study
News
ASX Small Caps Lunch Wrap: Who spent $150k on a piece of violent hip-hop history today?
News
ASX Small Caps Lunch Wrap: Who else should try to lose some risk appetite today?
News
ASX Small Caps and IPO Weekly Wrap: 30 hours of hot ASX action and we’re right back where we started
News
Rise and Shine: Everything you need to know before the ASX opens
News
